These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 16928215

  • 1. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
    González-Cuevas J, Bueno-Topete M, Armendariz-Borunda J.
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
    [Abstract] [Full Text] [Related]

  • 2. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].
    Li Q, Zhou X, Yu J, Qian W, Xu KS.
    Zhonghua Yi Xue Za Zhi; 2008 May 13; 88(18):1273-8. PubMed ID: 18844103
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC, Quax PH, Löwik CW, Verheijen JH.
    J Bone Miner Res; 1995 Sep 13; 10(9):1374-84. PubMed ID: 7502710
    [Abstract] [Full Text] [Related]

  • 5. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K, Palm J, König J, Seeland U, Rosenkranz S, Feiden W, Rübe C, Rübe CE.
    Int J Radiat Biol; 2007 Oct 13; 83(10):665-76. PubMed ID: 17729161
    [Abstract] [Full Text] [Related]

  • 6. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.
    Nephrol Dial Transplant; 2006 Sep 13; 21(9):2406-16. PubMed ID: 16728425
    [Abstract] [Full Text] [Related]

  • 7. Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down-regulation and up-regulation of MMPs, HGF and VEGF.
    Bueno M, Salgado S, Beas-Zárate C, Armendariz-Borunda J.
    J Gene Med; 2006 Nov 13; 8(11):1291-9. PubMed ID: 16958060
    [Abstract] [Full Text] [Related]

  • 8. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
    Badier-Commander C, Verbeuren T, Lebard C, Michel JB, Jacob MP.
    J Pathol; 2000 Sep 13; 192(1):105-12. PubMed ID: 10951407
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: a potential role in connective tissue destruction.
    Bodet C, Andrian E, Tanabe S, Grenier D.
    J Cell Physiol; 2007 Jul 13; 212(1):189-94. PubMed ID: 17299802
    [Abstract] [Full Text] [Related]

  • 12. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang Y, Urbanski SJ.
    Am J Pathol; 1998 Dec 13; 153(6):1895-902. PubMed ID: 9846979
    [Abstract] [Full Text] [Related]

  • 13. N1-acetyl substituted pyrrolidine derivative CIP-A5: a novel compound that could ameliorate liver cirrhosis through modulation of hepatic stellate cell activity.
    Wang XD, Gao ZH, Xue X, Cheng YN, Yue P, Fang XW, Qu XJ.
    Toxicol In Vitro; 2011 Jun 13; 25(4):897-904. PubMed ID: 21349324
    [Abstract] [Full Text] [Related]

  • 14. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD, Song KS, Li G, Choi H, Park HD, Lim K, Hwang BD, Yoon WH.
    BMC Cancer; 2006 Aug 18; 6():211. PubMed ID: 16916471
    [Abstract] [Full Text] [Related]

  • 15. Effects of different molecular weight hyaluronan products on the expression of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.
    Hsieh YS, Yang SF, Lue KH, Chu SC, Lu KH.
    J Orthop Res; 2008 Apr 18; 26(4):475-84. PubMed ID: 17975844
    [Abstract] [Full Text] [Related]

  • 16. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
    Ito K, Ryuto M, Ushiro S, Ono M, Sugenoya A, Kuraoka A, Shibata Y, Kuwano M.
    J Cell Physiol; 1995 Feb 18; 162(2):213-24. PubMed ID: 7822431
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
    Hu PF, Zhu YW, Zhong W, Chen YX, Lin Y, Zhang X, Yin C, Yue HY, Xie WF.
    J Gastroenterol Hepatol; 2008 Dec 18; 23(12):1917-25. PubMed ID: 18761555
    [Abstract] [Full Text] [Related]

  • 18. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR, Silence J, Lemmens G, Frederix L, Collen D.
    Thromb Haemost; 1998 Jun 18; 79(6):1171-6. PubMed ID: 9657444
    [Abstract] [Full Text] [Related]

  • 19. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
    Rabot A, Sinowatz F, Berisha B, Meyer HH, Schams D.
    J Dairy Sci; 2007 Feb 18; 90(2):740-8. PubMed ID: 17235151
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP.
    Am J Hypertens; 2004 Sep 18; 17(9):775-82. PubMed ID: 15363819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.